Literature DB >> 8938533

Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients.

J P Watson1, D J Bevitt, G P Spickett, G L Toms, M F Bassendine.   

Abstract

BACKGROUND: Heterogeneities in the buoyant density of hepatitis C virus RNA have been reported in different groups of patients, and have been attributed to differential binding of viral particles to beta-lipoproteins and IgG, and the presence of hepatitis C virus nucleocapsids in circulation. It may be that hepatitis C virus density heterogeneity correlates with the severity of liver disease, hepatitis C virus RNA titre, and the immunocompetence of the patient. METHODS AND
RESULTS: We have analysed five immunodeficient patients (one with hypogammaglobulinaemia and selective IgA deficiency, one with X-linked agammaglobulinaemia, three with common variable immunodeficiency) who have been acutely infected with the same batch of intravenous immunoglobulin contaminated with hepatitis C virus (genotype 1a). The course of hepatitis C virus infection in these patients was compared to one immunocompetent patient who presented with acute hepatitis C virus and progressed to chronic disease, and seven immunocompetent patients with chronic hepatitis C. Serum samples were analysed by differential flotation ultracentrifugation in NaCl solution (density 1.063 g/ml). The high and low density fractions were tested for the presence of RNA by RT-PCR. Serum samples were also quantified for hepatitis C virus RNA (Amplicor HCV Monitor kit, Roche Diagnostic Systems). Three quarters of the acutely infected patients analysed presented with low density hepatitis C virus. Low density hepatitis C virus was absent in most chronic infections but persisted in two patients with common variable immunodeficiency. High density hepatitis C virus was detected in the chronic phase in all acutely infected patients in whom the disease persisted, and was present in all samples from PCR-positive patients with chronic infection. Immunodeficient patients had significantly higher hepatitis C virus RNA titres on presentation than immunocompetent patients, but there was no correlation between titre and clinical course of infection.
CONCLUSIONS: Heterogeneities in the buoyant density of hepatitis C virus RNA have been identified in the patient groups studied. Low density hepatitis C virus is detected more often in acute infection and high density hepatitis C virus is detected more often in chronic infection. Despite acute infection via the same route of infection with the same hepatitis C virus strain, the five immunodeficient patients studied all followed a different clinical course.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938533     DOI: 10.1016/s0168-8278(96)80226-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status.

Authors:  Nikki Rae Adler; Marian Biddle; Lauren Beswick; Christopher Hair; Benjamin Allen; Stephen Graves; Aminul Islam; Jonathan P Watson
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

2.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Persistent hepatitis C virus infection in vitro: coevolution of virus and host.

Authors:  Jin Zhong; Pablo Gastaminza; Josan Chung; Zania Stamataki; Masanori Isogawa; Guofeng Cheng; Jane A McKeating; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 4.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

5.  Binding of liver derived, low density hepatitis C virus to human hepatoma cells.

Authors:  Caroline Martin; Soren U Nielsen; Siti Ibrahim; Margaret F Bassendine; Geoffrey L Toms
Journal:  J Med Virol       Date:  2008-05       Impact factor: 2.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.